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a  b  s  t  r  a  c  t
A  47-year-old  Japanese  woman  was transported  to  our  hospital  due  to  acute  heart failure  (AHF).  She had
been diagnosed  with  primary  hyperparathyroidism  (pHPT)  and  undergone  parathyroidectomy  3 months
previously.  Chest  X-ray  showed  marked  cardiomegaly  and  severe  pulmonary  congestion,  and  transtho-
racic echocardiography  indicated  both  left  ventricular  (LV)  systolic  and  diastolic  dysfunction,  complicated
with  extensive  massive  myocardial  calciﬁcation  and  no  LV  hypertrophy.  Computed  tomography  also
showed  massive  myocardial  calciﬁcation  in  the  posterior  wall  of  the  LV  and  the interventricular  septum.
After  treatment  with  furosemide,  olprinone,  and  carperitide  under  Swan-Ganz  monitoring,  LV  ejection
fraction  was  almost  normalized.  However,  cardiac  catheterization  in the  chronic  phase  indicated  that LV
diastolic  dysfunction  still  existed,  which  might  be  affected  by  myocardial  calciﬁcation.  We  followed  thisrimary hyperparathyroidism patient  using  spironolactone  (25 mg/day),  perindopril  (8 mg/day),  and  bisoprolol  (1.25  mg/day),  with  no
further episode  of  heart failure  for at least 6 months.  Here,  we  report  a  rare case  of AHF  complicated  with
massive  myocardial  calciﬁcation  possibly  caused  by  primary  hyperparathyroidism.
<Learning  objective:  This  is the  ﬁrst  case  report  of  acute  heart  failure  due  to left ventricular  systolic
and  diastolic  dysfunction,  complicated  with  massive  myocardial  calciﬁcation,  “porcelain  heart”,  possibly
caused  by  primary  hyperparathyroidism.>
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Massive myocardial calciﬁcation, so-called “porcelain heart”
1], is a rare disorder, as only some cases have been previously
eported [1–10]. The disorder may  be caused by either dystrophic
r metastatic calciﬁcation [11]. Dystrophic calciﬁcation is caused
y myocardial damage associated with tuberculosis, endomyocar-
ial ﬁbrosis, irradiation, and some cardiac tumors [12–15], while
etastatic calciﬁcation by abnormal calcium metabolism is related
o parathyroid hormone (PTH) hyperactivity associated with pri-
ary and secondary hyperparathyroidism [16,17]. It has also beeneported that massive myocardial calciﬁcation might cause heart
ailure by impaired cardiac motion [2]. Here, we  report a rare case
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of acute heart failure (AHF) complicated with massive myocardial
calciﬁcation, possibly caused by primary hyperparathyroidism.
Case report
A 47-year-old Japanese female patient, with a history of primary
hyperparathyroidism (parathyroid adenoma, maximum serum cal-
cium level of 23 mg/dl) and no complication of multiple endocrine
neoplasia or neoplasm, was transported to an emergency room in
our hospital due to worsening exertional dyspnea. She had been
surgically treated with parathyroidectomy 3 months earlier and
needed rehabilitation for 3 months. She had no history of smoking,
hypertension, or dyslipidemia, and no episode of any myocardial
scarring diseases, such as tuberculosis, endomyocardial ﬁbrosis,
irradiation, or cardiac tumors. On admission, her height was
159 cm and her weight was  48 kg, which was about 10 kg heavier
than usual. Physical examination revealed that blood pressure was
175/130 mmHg, pulse rate 105 bpm, and respiratory rate 22 per
minutes with orthopnea. She had third and fourth heart sounds and
vier Ltd. All rights reserved.
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nspiratory moist rales in bilateral lung ﬁelds, jugular venous dis-
ention, and cold extremity without leg edema. Electrocardiogram
howed low voltage in limb leads and poor R-wave progression
n precordial leads (Fig. 1A, left). Blood test showed normal renal
unction, normal liver function, low serum potassium level (K
.8 mEq/l), undernutrition (total protein 5.7 g/dl, albumin 2.9 g/dl),
o elevation of creatinine kinase (CK) (46 IU/l), CK-MB (11 IU/l),
nd cardiac troponin T (0.051 ng/ml), and elevated plasma level
f brain natriuretic peptide (BNP) (1915 pg/ml). Intact PTH was
lightly elevated (81 pg/ml) and corrected serum calcium level was
ormal (9.5 mg/dl). Antinuclear antibodies and rheumatoid factors
ig. 1. Images of the patient. (A) Electrocardiogram (ECG) at admission and on day 30 sh
n  precordial leads. Flat T waves in leads of I, aVL, V5, and V6 were normalized in 30 days
mproved at day 11. (C) Echocardiographic parasternal long-axis view and short-axis view
omography of the heart at day 17 showed extensive calciﬁcation mainly in the left ven
entricle; PE, pericardial effusion; RV, right ventricle.logy Cases 8 (2013) 183–186
were negative. The ratio of aldosterone concentration (445 pg/ml)
to plasma renin activity (5.2 ng/ml/h) was  within normal range
(85.5 pg/ml/ng/ml/h).
Chest X-rays showed marked cardiomegaly and pulmonary
congestion (Fig. 1B, left). Transthoracic echocardiography demon-
strated impaired left ventricular (LV) systolic function without LV
dilation (LV ejection fraction 21%, LV end-diastolic diameter 42 mm,
and end-systolic diameter 38 mm),  mild left atrial dilatation (left
atrial dimension 41.7 mm),  dilated inferior vena cava (expiratory
diameter 16 mm,  inspiratory 14 mm)  and LV diastolic dysfunction
[deceleration time of E wave (Dct) 148 ms], velocity ratio of E wave
owed a sinus rhythm with low voltage in limb leads and poor R-wave progression
. (B) Chest X-ray at admission showed marked cardiomegaly, which was markedly
 at admission showed acoustic shadowing and pericardial effusion. (D) Computed
tricle. (E) Endomyocardial biopsy sample (magniﬁcation 20×). Ao, aorta; LV, left
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o A wave (E/A) 1.18, early diastolic septal mitral annular velocity on
issue Doppler (e′ 5.34 cm/s and E/e′ 18.4) with no LV hypertrophy
interventricular septal thickness 8.0 mm,  posterior wall thickness
.6 mm).  Furthermore, M-mode image showed congruous motion
f the interventricular septum and the LV posterior wall, which
hould reﬂect pendular motion of heart due to pericardial effu-
ion [18]. Signiﬁcant regurgitation and stenosis in each heart valve
ere not observed. Acoustic shadowing and pericardial effusion
ollection were also detected (Fig. 1 C). Computed tomography (CT)
can of the heart in the previous hospital had detected the exten-
ive calciﬁcation mainly in the LV. CT scans of the brain, aorta,
ung, abdomen, and pelvis did not show any evidence of calcium
eposition in those organs. Heart magnetic resonance imaging
MRI) showed delayed contrast effect in septal to inferior wall.
hallium-201 myocardial perfusion scintigraphy showed no per-
usion defect of LV. Cardio Ankle Vascular Index (CAVI) measured on
1 days showed slight elevation (CAVI right 8.7, left 9.2, reference
alue < 9.0). These images suggested that AHF was caused by both
yocardial constriction and LV systolic dysfunction. The patient
as treated with intravenous furosemide (20 mg/day) and intra-
enous olprinone (0.1 g/kg/min) in the intensive care unit (ICU).
uring the 2nd to 8th ICU days, we monitored her hemodynam-
cs using Swan-Ganz catheter (Fig. 2). On day 11, her cardiomegaly
nd pulmonary congestion resolved (Fig. 1B, right), although on
ay 17, CT scan showed that myocardial calciﬁcation still existed
Fig. 1D). Cardiac catheterization and endomyocardial biopsy were
erformed on day 39, demonstrating that pulmonary artery wedge
ressure was 3 mmHg, mean pulmonary artery pressure 14 mmHg,
ardiac index (by thermodilution method) 2.7 L/min/m2, and LV
jection fraction 58%. Coronary angiography showed normal right
nd left coronary arteries. After loading of 500 ml  physiological
aline in 15 min, LV systolic and end-diastolic pressures were
arkedly elevated from 120/5 to 135/15 mmHg  (Table 1). Endomy-
cardial biopsy from the septum of right ventricle showed the
roliferation of collagenous ﬁber with hyaline degeneration in
ig. 2. Clinical course. Medical therapy was performed with diuretics, vasodila-
ors and inotropics under monitoring her hemodynamics using Swan-Ganz (S-G)
atheter. BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pres-
ure; HR, heart rate; EF, ejection fraction; hANP, human atrial natriuretic peptide;
NP, brain natriuretic peptide.
able 1
emodynamics values during cardiac catheterization on day 39.
RAP RVP PAP 
Pressure before loading saline (mmHg) (0) 25/0–2 24/7(14)
Pressure after loading saline (mmHg) (2) 34/1–5 34/14(20
oP, aortic pressure; CI, cardiac index, LVP, left ventricular pressure; PAP, pulmonary arter
VP,  right ventricular pressure.logy Cases 8 (2013) 183–186 185
the endocardium, with no evidence of calcium deposition, inﬂam-
matory cell inﬁltration, anisonucleosis, or myocardial disarray in
the myocardium (Fig. 1E). On day 47, she was discharged from
the hospital. She continued to receive spironolactone (25 mg/day),
perindopril (8 mg/day), and bisoprolol (1.25 mg/day) with no sub-
sequent episodes of heart failure thereafter; however, LV diastolic
dysfunction still remained at 6 months after discharge (Dct 325 ms,
E/A 0.79, E/e′ 14.0).
Discussion
To the best of our knowledge, this is the ﬁrst case report of AHF
complicated with “porcelain heart” due to LV systolic and diastolic
dysfunction. Although it has been reported that pHPT can cause LV
diastolic dysfunction due to LV hypertrophy or myocardial calciﬁ-
cation, this case had no LV hypertrophy. Furthermore, although it
has been demonstrated that LV systolic function is not affected by
pHPT [19], this case had transient LV systolic dysfunction. There-
fore, we  consider that in this case, transient LV systolic dysfunction
mainly caused the occurrence of AHF by unknown mechanism(s),
at least unrelated to myocardial infarction, myocarditis, or Takot-
subo cardiomyopathy. PTH also affects vascular endothelium and
smooth muscle cells, and subsequently causes hypertension, which
might contribute to occurrence of HF [19]. It has been reported that
the impaired vascular function is reversed by parathyroidectomy
before having structural changes, such as vascular calciﬁcation [19].
We were unable to assess her arterial stiffness in acute phase; how-
ever, CAVI was  nearly normal in the chronic phase. Although we
have no data regarding the impaired arterial stiffness, it might
play a partial role to develop HF in this case. One of the possi-
ble mechanisms of AHF in this case might be that the afterload
mismatch caused transient LV systolic dysfunction as the extreme
hypertension was  present at admission and the afterload reduction
therapy, such as carperitide, perindopril, olprinone, and nicardi-
pine, improved hemodynamics and increased cardiac output. In
fact, her LV systolic function was almost normalized during 6
months after discharge.
To date, only 9 cases with massive myocardial calciﬁcation asso-
ciated with hyperparathyroidism have been reported, all of which
were complicated with secondary hyperparathyroidism in renal
failure [2–10]. Since myocardial calciﬁcation is rarely detected, due
to the limited opportunities to take CT scans of the heart [1], it is
difﬁcult to demonstrate how long myocardial calcium deposition
exists as in our case. Although the causes of massive and local-
ized myocardial calciﬁcation in this patient are unclear, it is well
known that there are two different pathophysiological pathways,
which might lead to myocardial calciﬁcation [11]. One is signiﬁcant
disturbance in calcium metabolism, which can result in ectopic cal-
ciﬁcation, and the other mechanism of myocardial calciﬁcation is
dystrophic calciﬁcation, which is associated with tissue damage.
The calcium accumulation in this case might be mainly due to the
former mechanism; however, it is unable to explain why  the cal-
ciﬁcation was localized only in heart. The endomyocardial biopsy
and cardiac MRI  indicated the existence of myocardial degenera-
tion accompanied with HF, suggesting that dystrophic factors due
to myocardial tissue damage can facilitate metabolic calciﬁcation
dominantly in myocardium.
PCWP LVP AoP CI (L/min/m2)
 (3) 118/1–5 103/44(77) 2.65
) (8) 135/6–15 115/55(93) 2.98
ial pressure; PCWP, Pulmonary capillary wedge pressure; RAP, right atrial pressure;
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After the improvement of AHF, we conﬁrmed that there was no
hange in her myocardial calciﬁcation on CT scan and that cardiac
atheterization showed exacerbated diastolic dysfunction after
oading test with physiological saline. Since it has been reported
hat myocardial calcium deposition causes reversible cardiac dys-
unction and irreversible structural changes [17], we consider that
yocardial calciﬁcation would not disappear in this case. Although
e conﬁrmed the existence of LV diastolic dysfunction in the
hronic phase of AHF, we  were unable to conclude to what extent
he myocardial calciﬁcation works on the LV diastolic dysfunction.
herefore, we should carefully follow this patient for a long time,
ot only for the medical treatment to prevent the recurrence of
HF but also for the observation of the serial changes in myocardial
alciﬁcation and LV diastolic dysfunction.
In summary, we report a rare case of AHF accompanied by mas-
ive myocardial calciﬁcation in a woman with a history of pHPT.
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